POTASSIUM CITRATE
These highlights do not include all the information needed to use POTASSIUM CITRATE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CITRATE EXTENDED-RELEASE TABLETS. POTASSIUM CITRATE Extended-release tablets for oral useInitial U.S. Approval: 1985
5f38b02c-703c-4fc2-b833-654e41bd617f
HUMAN PRESCRIPTION DRUG LABEL
May 25, 2023
Strides Pharma Inc.
DUNS: 078310501
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
POTASSIUM CITRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
POTASSIUM CITRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
POTASSIUM CITRATE
Product Details
FDA regulatory identification and product classification information